位置：成果数据库 > 期刊 > 期刊详情页
Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44(+) Cells and Ev
  • ISSN号：1932-6203
  • 期刊名称：PLos One
  • 时间：0
  • 页码：-
  • 相关项目：CCR9介导的急性淋巴细胞性白血病耐药分子机制的研究
作者： Yan, Hong|Fokt, Izabela|Skora, Stanislaw|Priebe, Waldemar|Bi, Yongyi|Tang, Dean G.|Chen, Xin|Zhang, Qiuping|Qin, Jichao|Li, Hangwen|Liu, Can|Calhoun-Davis, Tammy|Della Coletta, Luis|Klostergaard, Ji
同期刊论文项目
CCR9介导的急性淋巴细胞性白血病耐药分子机制的研究
期刊论文 19
同项目期刊论文
Activation of β-catenin signaling is critical for doxorubicin-induced epithelial-mesenchymal tr
Arg9 facilitates the thansslocation and downstream signal inhibition of an anti-HER2 single chain an
WT1基因在急性髓系白血病中的作用研究
自体外周血造血干细胞移植治疗糖尿病足的临床观察
熊果酸对大鼠实验性大肠癌的化学预防作用
视黄醇结合蛋白4、胰岛素抵抗和人类代谢性疾病
Leukemia stem cells in drug resistance and metastasis
Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25
Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9
Anaplastic myeloma and T-cell lymphoma in the same patient.
表皮生长因子受体家族单克隆抗体耐药机制的研究进展
甲状旁腺囊肿临床分析
儿童多发性硬化的临床特征及预后